These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 21814558

  • 1. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.
    Li MS, Lau TC, Chan SK, Wong CH, Ng PK, Sung JJ, Chan HL, Tsui SK.
    PLoS One; 2011; 6(7):e21856. PubMed ID: 21814558
    [Abstract] [Full Text] [Related]

  • 2. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
    Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trépo C, Wands J, Tong S.
    J Virol; 2003 Jun; 77(12):6601-12. PubMed ID: 12767980
    [Abstract] [Full Text] [Related]

  • 3. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM, Jang JW, Yoo SH, Kim SH, Oh IM, Park SJ, Jang YS, Lee SJ.
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [Abstract] [Full Text] [Related]

  • 4. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy.
    Peng Y, Liu B, Hou J, Sun J, Hao R, Xiang K, Yan L, Zhang J, Zhuang H, Li T.
    Antivir Ther; 2015 Mar; 20(6):623-32. PubMed ID: 25838313
    [Abstract] [Full Text] [Related]

  • 5. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma.
    Venard V, Corsaro D, Kajzer C, Bronowicki JP, Le Faou A.
    J Med Virol; 2000 Oct; 62(2):177-84. PubMed ID: 11002246
    [Abstract] [Full Text] [Related]

  • 7. Association of core promoter mutations of hepatitis B virus and viral load is different in HBeAg(+) and HBeAg(-) patients.
    Utama A, Siburian MD, Purwantomo S, Intan MD, Kurniasih TS, Gani RA, Achwan WA, Arnelis, Lelosutan SA, Lukito B, Harmono T, Zubir N, Julius, Soemohardjo S, Lesmana LA, Sulaiman A, Tai S.
    World J Gastroenterol; 2011 Feb 14; 17(6):708-16. PubMed ID: 21390140
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.
    Tatsukawa M, Takaki A, Shiraha H, Koike K, Iwasaki Y, Kobashi H, Fujioka S, Sakaguchi K, Yamamoto K.
    BMC Cancer; 2011 Oct 21; 11():458. PubMed ID: 22014121
    [Abstract] [Full Text] [Related]

  • 9. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ, Yoo BC.
    Taehan Kan Hakhoe Chi; 2002 Jun 21; 8(2):149-56. PubMed ID: 12499800
    [Abstract] [Full Text] [Related]

  • 10. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW, Chun JY, Park YM, Shin SK, Yoo W, Kim SO, Hong SP.
    Cancer Sci; 2012 Feb 21; 103(2):296-304. PubMed ID: 22136288
    [Abstract] [Full Text] [Related]

  • 11. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 21; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 12. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
    Chen RY, Bowden S, Desmond PV, Dean J, Locarnini SA.
    J Gastroenterol Hepatol; 2003 Jun 21; 18(6):630-7. PubMed ID: 12753143
    [Abstract] [Full Text] [Related]

  • 13. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
    Wang Y, Wei L, Jiang D, Cong X, Fei R, Chen H, Xiao J, Wang Y.
    Antiviral Res; 2007 Aug 21; 75(2):139-45. PubMed ID: 17397939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
    Fan HX, Feng YJ, Zhao XP, He YZ, Tang H.
    Life Sci; 2018 Nov 15; 213():9-17. PubMed ID: 30308183
    [Abstract] [Full Text] [Related]

  • 17. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
    Ochwoto M, Chauhan R, Gopalakrishnan D, Chen CY, Ng'ang'a Z, Okoth F, Kioko H, Kimotho J, Kaiguri P, Kramvis A.
    Infect Genet Evol; 2013 Dec 15; 20():103-10. PubMed ID: 23978387
    [Abstract] [Full Text] [Related]

  • 18. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
    Tian H, He Z.
    Biomed Pharmacother; 2018 Mar 15; 99():774-780. PubMed ID: 29710475
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.
    Nagasaka A, Hige S, Marutani M, Tsunematsu I, Saito M, Yamamoto Y, Konishi S, Asaka M.
    Dig Dis Sci; 1998 Nov 15; 43(11):2473-8. PubMed ID: 9824137
    [Abstract] [Full Text] [Related]

  • 20. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH.
    Liver Int; 2005 Jun 15; 25(3):564-70. PubMed ID: 15910494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.